Major Depressive Disorders
Conditions
Keywords
Major Depressive Disorder (MDD), Blended treatment, Cognitive behavior Therapy (CBT), Face-to-face, internet-based treatment
Brief summary
To asses the clinical effectiveness of blended cognitive behavior therapy (CBT): face-to-face and internet-based treatment for adults with Major Depressive Disorder (MDD) in primary care compared to treatment as usual.
Detailed description
The study is part of a EU-project. Participants are recruited via regular routes from primary care settings. Following the Mini International Neuropsychiatric Interview (M.I.N.I.) participants will be randomly allocated to either blended treatment for 10 sessions/weeks or to treatment as usual. We will include 150 participants in total.
Interventions
CBT based on behavioral activation and cognitive therapy techniques including homework
Treatment as usual in primary care including antidepressants and counselling
Sponsors
Study design
Eligibility
Inclusion criteria
* depressive symptoms according to DSM-IV * have access to a computer with internet connection * have good knowledge of the Swedish language
Exclusion criteria
* recent (during last 6 weeks) change in psychiatric medication * presently in any other psychological treatment * severe depression * suicidal ideation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Quick Inventory of Depressive Symptomatology Self-Report (QIDS | Change from baseline in symptoms of depression. Time Frame: 0, 3, 6 and 12 months | Symptoms of depression measured by the QIDS. The QIDS is a questionnaire that screens for depressive symptoms and assesses depression severity. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Client Satisfaction Questionnaire (CSQ-8) | Time Frame: 3 months (post treatment) | Patient's satisfaction with the treatment is assessed with Client Satisfaction Questionnaire (CSQ-8) |
| Credibility and Expectancy Questionnaire (CEQ) | Time Frame: 3 months (post treatment) | Patients' expectancy of treatment will be assessed with the credibility and expectancy questionnaire (CEQ) |
| System Usability Scale (SUS) | Time Frame: 3 months (post treatment) | Satisfaction with the internet platform will be evaluated with the system usability scale (SUS) |
| EuroQol-5D (EQ-5D-5L) | Time Frame: 0, 3, 6 and 12 months | Quality of life will be assessed with the EQ-5D-5L (EuroQol). The EQ-5D-5L is a self-report questionnaire which measures health related quality of life. |
| Working Alliance Inventory (WAI-SF) | Time Frame: 0 months ( three weeks after started treatment) | The therapeutic alliance between therapists and patient will be assessed with the short version of the Working Alliance Inventory (WAI-SF). |
| Trimbos and iMTA questionnaire on Costs associated with Psychiatric illness (TIC-P) | Time Frame: 0, 3, 6 and 12 months | Health service uptake and production loss due to illness will be measured with the Trimbos and iMTA Questionnaires on Costs Associated with Psychiatric Illness (TiC-P) |
| Patient Health Questionnaire (PHQ-9) | Time Frame: 0, 3, 6 and 12 months | The PHQ-9 is a nine-item mood module that can be used to screen and to diagnose patients with depressive disorders. |
Countries
Sweden